# Soufflé Therapeutics

**Canonical:** https://apis.io/providers/souffl-therapeutics/  
**Website:** https://www.souffletx.com/  
**APIs profiled:** 0

Soufflé Therapeutics is a genetic medicine company developing nucleic acid (siRNA) therapeutics that use proprietary cell-specific ligand-conjugation technology to target and deliver treatments to specific cell types. Its initial programs address muscle and heart disorders, with first therapies targeting Facioscapulohumeral Muscular Dystrophy (FSHD) and genetically-driven cardiomyopathies, with clinical trials expected to begin in 2026. The company is headquartered in Watertown, Massachusetts and was surfaced through the API Evangelist network as a portfolio company of Bessemer Venture Partners. It is a therapeutics/pharmaceutical company and publishes no public API, developer portal, or SDK surface.

## Kin Score — 5.0 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 5.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Souffl Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotech, Therapeutics, Genetic Medicine, siRNA, RNA Therapeutics, Pharmaceuticals

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/souffl-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.